Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website (MIBS trial)

Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website (MIBS trial)

Show other versions (1)

Background: IBS affects 10-22% of the UK population. Abdominal pain, bloating and altered bowel habit affect quality of life, social functioning and time off work. Current GP treatment relies on a positive diagnosis, reassurance,lifestyle advice and drug therapies, but many suffer ongoing symptoms....

Full description

Bibliographic Details
Main Authors: Everitt, Hazel A. (Author), Moss-Morris, Rona E. (Author), Sibelli, Alice (Author), Tapp, Laura (Author), Coleman, Nicholas S. (Author), Yardley, Lucy (Author), Smith, Peter W. (Author), Little, Paul S. (Author)
Format: Article
Language:English
Published: 2010.
Subjects:
Article
Online Access:Get fulltext
Show all versions (2)

Similar Items